The simultaneous C-suite selling is a bearish signal despite the small dollar amount relative to market cap. Monitor for any upcoming negative catalysts (e.g., clinical trial results, regulatory setbacks, or earnings miss) that could explain the insider behavior. The strong historical positive drift for this filing type suggests the market may ignore the signal initially, but the pattern warrants caution for long positions.
SYRE drugs
SYRE drug pipeline →How the stock moved after the report
BEARISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Aug 6 $103.42entry
- T+1 · 3mo ago +1.44%α +0.83% · $104.91
- T+5 · 3mo ago −1.52%α −2.73% · $101.85
- T+20 · 3mo ago −15.64%α −16.24% · $87.25
- T+60 · 18d ago −6.63%α −4.96% · $96.56
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
CEO Turtle Cameron and CFO Scott Burrows sold a combined $561K in open-market sales on August 3, 2026, with the CEO selling $1.4M total across multiple trades. The CFO also exercised 7,500 derivative shares at $0 and sold 7,500 shares at an average of ~$95.60. While the dollar amount is modest relative to SYRE's $9.2B market cap (0.006%), the cluster involves both top C-suite executives selling on the same day, which warrants attention.
Key Financial Metrics
Key Facts
- CEO Turtle Cameron sold $1.4M in open-market sales on August 3, 2026
- CFO Scott Burrows sold $717K in open-market sales on August 3, 2026
- Total insider selling in the cluster: ~$2.1M over 30 days, with $561K in the last 7-day window
- Both top C-suite executives sold on the same day, a pattern often associated with shared information
- The company has a $9.2B market cap and 91% analyst bullish consensus
Financial Impact
CEO and CFO sold ~$2.1M combined over 30 days, with $561K in the last week; 0.006% of market cap
Risk Factors
- Insider selling may indicate upcoming negative news or management concerns about valuation
- CEO and CFO selling on the same day could signal shared bearish view
- The small dollar amount relative to market cap may limit the signal's impact
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-SYRE-1785981673482 |
Track record
36 reports on SYRE
7 of 11 bullish or bearish reports moved the stock their way by T+60. Best: +54.27% at T+60 after the Apr 13, 2026 report. 14 of 20 went positive at some point.
Filters
- Nov 3, 202613d ago 8-K Neutral 5/10 No price data
- Nov 3, 202613d ago Press Release Bearish 5/10 Entry $99.04 Now $99.37 −0.33% settles Feb 2
- Oct 12, 20265w ago Institutional Cluster Bullish 4/10 Entry $85.90 Now $99.37 +15.68% settles Jan 7
- Oct 9, 20265w ago SC 13D/A Neutral 3/10 Entry $85.90 Now $99.37 +15.68% settles Jan 7
- Oct 7, 20265w ago 8-K Bearish 5/10 Entry $80.85 Now $99.37 −22.91% settles Jan 4
- Oct 6, 20265w ago 424B5 Bearish 6/10 Entry $80.85 Now $99.37 −22.91% settles Jan 4
- Oct 5, 20266w ago Press Release Bearish 6/10 Entry $80.11 Now $99.37 −24.04% settles Dec 31
- Oct 5, 20266w ago 424B5 Bearish 5/10 Entry $80.11 Now $99.37 −24.04% settles Dec 31
- Oct 5, 20266w ago Press Release Bearish 5/10 Entry $80.11 Now $99.37 −24.04% settles Dec 31
- Oct 2, 20266w ago Insider Cluster Bearish 4/10 Entry $92.72 Now $99.37 −7.17% settles Dec 30
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers